James C. Romero-Masters

A cancer-associated Epstein-Barr virus BZLF1 promoter variant enhances lytic infection

Jillian A. Bristol, Reza Djavadian, Emily R. Albright et al. · PLoS Pathogens · 2018 · 92 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

Leflunomide/teriflunomide inhibit Epstein-Barr virus (EBV)-induced lymphoproliferative disease and lytic viral replication

Andrea Bilger, Julie Plowshay, Shidong Ma et al. · Oncotarget · 2017 · 77 citations · Full text

Life Sciences, Immunology, Oncology +10

Hypoxia-inducible factor-1α plays roles in Epstein-Barr virus’s natural life cycle and tumorigenesis by inducing lytic infection through direct binding to the immediate-early BZLF1 gene promoter

Richard J. Kraus, Xianming Yu, Blue-leaf A. Cordes et al. · PLoS Pathogens · 2017 · 77 citations · Full text

Medicine, Cancer Biology, Oncology +17

Adoptively transferred Vγ9Vδ2 T cells show potent antitumor effects in a preclinical B cell lymphomagenesis model

Nicholas A. Zumwalde, Akshat Sharma, Xuequn Xu et al. · JCI Insight · 2017 · 66 citations · Full text

Life Sciences, Immunology, Oncology +17

Latent Membrane Protein 1 (LMP1) and LMP2A Collaborate To Promote Epstein-Barr Virus-Induced B Cell Lymphomas in a Cord Blood-Humanized Mouse Model but Are Not Essential

Shi-Dong Ma, Ming‐Han Tsai, James C. Romero-Masters et al. · Journal of Virology · 2017 · 45 citations · Full text

Life Sciences, Molecular Biology, Oncology +17